{"data": [{"id": "data_1", "omics": "Proteomics", "link": "http://ptrc.cptac-data-view.org/", "format": "Processed Data", "source": "Proteomic Data Commons", "public_id": "PDC000357"}, {"id": "data_2", "omics": "Proteomics", "link": "http://ptrc.cptac-data-view.org/", "format": "Processed Data", "source": "Proteomic Data Commons", "public_id": "PDC000358"}, {"id": "data_3", "omics": "Proteomics", "link": "http://ptrc-data.org", "format": "tsv", "source": "Proteomic Data Commons", "public_id": "PDC000360"}], "analyses": [{"id": "analysis_1", "analysis_type": "Differential Expression Analysis", "analysis_data": ["data_1", "data_2"], "label": {"treatment_response": ["sensitive", "refractory"]}, "description": "Identifies differentially expressed proteins between sensitive and refractory tumors."}, {"id": "analysis_2", "analysis_type": "Pathway Enrichment Analysis", "analysis_data": ["data_1", "data_2"], "description": "Performs pathway enrichment analysis to identify biological processes associated with treatment response."}, {"id": "analysis_3", "analysis_type": "Prognostic Biomarker Discovery", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"tumor_type": ["tumor_subtypes"]}, "description": "Discovers prognostic biomarkers associated with tumor subtypes."}, {"id": "analysis_4", "analysis_type": "Survival Analysis", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"overall_survival_time": [365, 730]}, "description": "Analyzes survival outcomes based on proteomic profiles."}, {"id": "analysis_5", "analysis_type": "Clustering Analysis", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"cluster_id": [1, 2, 3, 4, 5]}, "description": "Clustering of tumor samples to identify distinct proteomic profiles."}, {"id": "analysis_6", "analysis_type": "Predictive Modeling", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"risk_group": ["low_risk", "high_risk"]}, "description": "Develops a predictive model for patient risk stratification."}, {"id": "analysis_7", "analysis_type": "Pathway Enrichment and Event-Free Survival Analysis", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"event_free_survival": ["recurrence_free", "relapse"]}, "description": "Associates pathway enrichment with event-free survival outcomes."}, {"id": "analysis_8", "analysis_type": "Multivariate Cox Regression", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"treatment_response": ["sensitive", "refractory"]}, "description": "Assesses the relationship between proteomic features and treatment response using Cox regression."}, {"id": "analysis_9", "analysis_type": "Prognostic Signature Development", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"risk_category": ["low_risk", "intermediate_risk", "high_risk"]}, "description": "Develops a prognostic signature for patient risk stratification using proteomic and genomic data."}, {"id": "analysis_10", "analysis_type": "Proteomic Clustering", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"subtypes": ["cluster_1", "cluster_2"]}, "description": "Clustering of proteomic profiles to identify molecular subtypes."}]}